Susquehanna International Group
AVIR icon

Susquehanna International Group’s Atea Pharmaceuticals AVIR Stock Holding History

Susquehanna International Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$418K Buy
+77,700
New +$357K ﹤0.01% 10107
2025
Q4 		– Sell
-22,900
Closed -$66.4K – 12309
2025
Q3 		$66.4K Buy
+22,900
New +$78.2K ﹤0.01% 11764
2024
Q3 		– Sell
-69,000
Closed -$228K – 11937
2024
Q2 		$228K Sell
69,000
-25,400
-27% -$94.7K ﹤0.01% 10061
2024
Q1 		$381K Buy
94,400
+76,500
+427% +$299K ﹤0.01% 9137
2023
Q4 		$54.6K Buy
17,900
+7,900
+79% +$23.9K ﹤0.01% 11681
2023
Q3 		$30K Buy
+10,000
New +$34K ﹤0.01% 11483
2023
Q1 		– Sell
-569,400
Closed -$2.74M – 12534
2022
Q4 		$2.74M Sell
569,400
-1,000
-0.2% -$5.06K ﹤0.01% 4161
2022
Q3 		$3.25M Buy
570,400
+83,800
+17% +$641K ﹤0.01% 3923
2022
Q2 		$3.46M Buy
486,600
+351,200
+259% +$2.4M ﹤0.01% 3821
2022
Q1 		$978K Sell
135,400
-174,100
-56% -$1.18M ﹤0.01% 7177
2021
Q4 		$2.77M Buy
309,500
+239,400
+342% +$3.73M ﹤0.01% 4797
2021
Q3 		$2.46M Sell
70,100
-25,000
-26% -$693K ﹤0.01% 5389
2021
Q2 		$2.04M Buy
95,100
+69,700
+274% +$2.09M ﹤0.01% 5871
2021
Q1 		$1.57M Buy
+25,400
New +$1.72M ﹤0.01% 6516

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Susquehanna International Group's AVIR Position: Q1 2026 in Review

Susquehanna International Group increased its Atea Pharmaceuticals (AVIR) stake by 377% in Q1 2026, buying an estimated $297K and bringing the position to 81,835 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #9987.

Susquehanna International Group first reported a position in AVIR in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.75M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Susquehanna International Group held 81,835 shares of Atea Pharmaceuticals worth $440K as of Q1 2026.
  • Susquehanna International Group bought 64,679 Atea Pharmaceuticals shares in Q1 2026, an estimated $297K.
  • Atea Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9987 holding.
  • Susquehanna International Group first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Susquehanna International Group's Atea Pharmaceuticals position peaked at $2.75M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.